Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
EverCommerce (EVCM) Launches 11M Share Offering
-
Atalaya Mining PLC Announces Exchange Rate of Inaugural Dividend
-
EverCommerce Announces Launch of Follow-On Offering
-
EverCommerce Announces Launch of Follow-On Offering
-
Clover Health (CLOV) Stock Dinged 9% on 35M Share Stock Offering
-
Definitive Healthcare (DH) Announces Launch of Proposed Follow-On Offering of 11M Shares of Class A Common Stock
-
Definitive Healthcare Announces Launch of Proposed Follow-On Offering of 11,000,000 Shares of Class A Common Stock
-
Definitive Healthcare Announces Launch of Proposed Follow-On Offering of 11,000,000 Shares of Class A Common Stock
-
CytoSorbents to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum and Jefferies London Healthcare Conference
-
KnowBe4 Announces Closing of Follow-On Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
-
KnowBe4 Announces Closing of Follow-On Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
-
Clover Health Investments (CLOV) Announces 35M Share Proposed Public Offering of Class A Common Stock
-
Clover Health Investments, Corp. Announces Proposed Public Offering of Class A Common Stock
-
Stewart Information Services (STC) Files For US IPO
-
Sangoma Announces Initial Public Offering in the United States
-
Sangoma Announces Initial Public Offering in the United States
-
Aziyo Biologics to Participate in Upcoming Virtual Investor Conferences
-
Oneview Healthcare PLC Successfully Completes A$20 Million Placement to Institutional Investors
-
System1 to Participate in Upcoming Investor Events
-
T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
-
Plant-Based Food & Beverage Company Led by All Women C-Suite and Board Completes IPO and Will Commence Trading on the TSX-V Under the Ticker Symbol "MYLK"
-
Jack Nathan Health to Present at Canaccord Genuity Health and Wellness Conference
-
Canaccord Genuity G Ventures Corp. Reports Third Quarter 2021 Financial Results
-
Givex Corporation and County Capital 2 Ltd. Announce Closing of Upsized $22 Million Private Placement and Uplisting to The Toronto Stock Exchange in Connection with Qualifying Transaction
-
Mynaric AG (MYNA) Prices 4M ADS IPO at $16.50/ADS
-
Mynaric has Announced Pricing of Initial Public Offering in the United States
-
Bioceres Crop Solutions to Participate in Upcoming Investor Conferences
-
Mynaric AG (MYNA) IPO Opens Higher
-
CalAmp Corp. (CAMP) PT Lowered to $15 at Canaccord Genuity
-
NervGen Pharma Completes $9.2 Million Bought Deal Financing
-
VSE Corporation (VSEC) PT Raised to $72 at Canaccord Genuity on Continued Strong Bizjet Flight Volume
-
Quanterix to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
-
Canaccord Genuity Downgrades Fortuna Silver Mines (FVI:CN) (FSM) to Sell
-
PacBio to Present at Upcoming Investor Conferences
-
PacBio to Present at Upcoming Investor Conferences
-
DoubleVerify CEO and CFO to Participate in Fireside Chat with Canaccord Genuity
-
Vericel to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum on November 18th, 2021
-
Vericel to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum on November 18th, 2021
-
Valuation is Monday.com's (MNDY) Biggest Hurdle, PT Raised to $430 at Canaccord Genuity
-
electroCore to Participate at Canaccord Genuity MedTech & Diagnostics Forum
-
Bounteous Acquires Hathway, Combination Will Drive the Next Generation of Restaurant and Convenience Store Digital Experiences
-
InterVenn Biosciences to Participate at Two Upcoming Investor Conferences in November
-
908 Devices to Participate in Upcoming Investor Conferences
-
Lyra Therapeutics to Present at Upcoming Virtual Investor Conferences
-
Element Nutritional Sciences to Present at Canaccord Health & Wellness Conference
-
Biodesix to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
-
KnowBe4, Inc (KNBE) Prices Upsized 9M Share Follow-on Offering by Selling Stockholders at $25.75/sh
-
KnowBe4 Announces the Upsize and Pricing of Follow-On Offering by Selling Stockholders
-
KnowBe4 Announces the Upsize and Pricing of Follow-On Offering by Selling Stockholders
-
Apyx Medical Corporation to Participate in Upcoming Investor Conferences in November and December

